Andrew Hebert

417 total citations
6 papers, 66 citations indexed

About

Andrew Hebert is a scholar working on Oncology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Andrew Hebert has authored 6 papers receiving a total of 66 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Pathology and Forensic Medicine and 2 papers in Immunology. Recurrent topics in Andrew Hebert's work include Cancer Mechanisms and Therapy (3 papers), Peptidase Inhibition and Analysis (3 papers) and MXene and MAX Phase Materials (2 papers). Andrew Hebert is often cited by papers focused on Cancer Mechanisms and Therapy (3 papers), Peptidase Inhibition and Analysis (3 papers) and MXene and MAX Phase Materials (2 papers). Andrew Hebert collaborates with scholars based in United States, Mexico and Germany. Andrew Hebert's co-authors include Mikhail Levit, Natalia V. Malkova, Alexei Protopopov, Dmitri Wiederschain, Frank F. Sun, Joachim Theilhaber, Jack Pollard, Rita Greco, Richard C. Gregory and Christopher Winter and has published in prestigious journals such as Cancer Research, Bioorganic & Medicinal Chemistry Letters and OncoImmunology.

In The Last Decade

Andrew Hebert

5 papers receiving 66 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew Hebert United States	4	47	26	21	19	13	6	66
Zonera Hassan Germany	4	88 1.9×	47 1.8×	8 0.4×	25 1.3×	39 3.0×	7	122
Donastas Sakellariou-Thompson United States	5	83 1.8×	65 2.5×	22 1.0×	60 3.2×	12 0.9×	10	138
James Berstler United States	4	40 0.9×	48 1.8×	15 0.7×	18 0.9×	13 1.0×	5	98
Sibasish Dolai Australia	4	61 1.3×	39 1.5×	27 1.3×	28 1.5×	6 0.5×	5	184
Lingyu He United States	3	14 0.3×	17 0.7×	12 0.6×	62 3.3×	13 1.0×	4	94
Eric M. Neiman United States	2	30 0.6×	68 2.6×	7 0.3×	19 1.0×	4 0.3×	4	82
Tiffany J. Tzeng United States	3	22 0.5×	29 1.1×	23 1.1×	16 0.8×	2 0.2×	4	63
Jeanne Yue United States	2	41 0.9×	53 2.0×	45 2.1×	10 0.5×	5 0.4×	2	89
Kirstin Petersen Germany	5	23 0.5×	81 3.1×	14 0.7×	7 0.4×	19 1.5×	11	95
Anna Calinawan United States	3	34 0.7×	54 2.1×	8 0.4×	8 0.4×	8 0.6×	4	100

Countries citing papers authored by Andrew Hebert

Since Specialization

Citations

This map shows the geographic impact of Andrew Hebert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Hebert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Hebert more than expected).

Fields of papers citing papers by Andrew Hebert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Hebert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Hebert. The network helps show where Andrew Hebert may publish in the future.

Co-authorship network of co-authors of Andrew Hebert

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Hebert. A scholar is included among the top collaborators of Andrew Hebert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Hebert. Andrew Hebert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Elliott, Rachel, et al.. (2023). Wound management provided by advanced practice nurses: a scoping review. JBI Evidence Synthesis. 22(5). 790–830.

2.

Barberis, Claude, Paul Erdman, Joseph D. Batchelor, et al.. (2020). Discovery of SARxxxx92, a pan-PIM kinase inhibitor, efficacious in a KG1 tumor model. Bioorganic & Medicinal Chemistry Letters. 30(23). 127625–127625. 7 indexed citations

3.

Malkova, Natalia V., Tatiana Tolstykh, Mikhail Levit, et al.. (2020). Abstract 4451: Combination of local mRNA immunotherapy with systemic immune checkpoint blockade demonstrates anti-tumor activity across a diverse range of preclinical syngeneic tumor models. Cancer Research. 80(16_Supplement). 4451–4451. 2 indexed citations

4.

Greco, Rita, Hongjing Qu, Hui Qu, et al.. (2020). Pan-TGFβ inhibition by SAR439459 relieves immunosuppression and improves antitumor efficacy of PD-1 blockade. OncoImmunology. 9(1). 1811605–1811605. 45 indexed citations

5.

Barberis, Claude, Paul Erdman, John Jiang, et al.. (2018). Discovery of N-substituted 7-azaindoles as Pan-PIM kinases inhibitors – Lead optimization – Part III. Bioorganic & Medicinal Chemistry Letters. 29(3). 491–495. 7 indexed citations

6.

Barberis, Claude, Paul Erdman, Tahir Majid, et al.. (2017). Discovery of N-substituted 7-azaindoles as Pan-PIM kinase inhibitors – Lead series identification – Part II. Bioorganic & Medicinal Chemistry Letters. 27(20). 4735–4740. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact